Public Profile

Universe Pharmaceuticals INC

Universe Pharmaceuticals Inc., headquartered in China, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in 2003, the company has established a strong presence in major operational regions across Asia and beyond, focusing on both prescription and over-the-counter medications. With a commitment to quality and efficacy, Universe Pharmaceuticals offers a diverse range of products, including generic drugs and specialty pharmaceuticals. Their unique approach to research and development has led to several key milestones, positioning them as a trusted name in the market. Notably, the company has received various certifications that underscore its dedication to regulatory compliance and product safety, further solidifying its reputation in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Universe Pharmaceuticals INC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Universe Pharmaceuticals INC's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

Universe Pharmaceuticals INC's reported carbon emissions

Universe Pharmaceuticals INC, headquartered in CN, currently does not have any publicly available data regarding its carbon emissions or specific climate commitments. As such, there are no reported figures for emissions in kg CO2e, nor are there established reduction targets or initiatives outlined in their sustainability strategy. In the absence of concrete data, it is unclear how the company is addressing climate change or its carbon footprint. This lack of information highlights a potential area for improvement in transparency and accountability regarding environmental impact within the pharmaceutical industry.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Universe Pharmaceuticals INC's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Universe Pharmaceuticals INC is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Universe Pharmaceuticals INC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Amway (China) Co. Ltd

CN
Chemicals nec
Updated 3 days ago
DitchCarbon Score

Sunflower Pharmaceutical Group Co.,Ltd

CN
Chemicals nec
Updated about 6 hours ago

Yunnan Baiyao

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 12 hours ago

Shinva Medical Instrument Co.,Ltd.

CN
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Baiyunshan

CN
Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c.
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers